Mark Christopher Capone
Director at Mesa Laboratories Inc /co/ (MLAB) since January 2024
Mark Christopher Capone has filed 12 insider reports with the SEC since July 2022, as director at Mesa Laboratories Inc /co/ (MLAB), director at Sera Prognostics, Inc. (SERA) and director at DermTech, Inc. (DMTK). In the last 12 months Mark Christopher Capone bought $99.3K of stock on the open market. The latest filing, on September 11, 2026, reports grant or award at Mesa Laboratories Inc /co/ (MLAB).
- Filings
- 12
- Companies
- 3
- Bought on market
- $99.3K
- Sold on market
- None
Companies where Mark Christopher Capone is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince January 2024 | 6,213 | $99.3K | $76.35 | $127.93+68% | Sep 11, 2026 | ||
| Directorsince July 2026 | 44,379 | $1.81 | Jul 14, 2026 | ||||
| Directorsince July 2022 | 82,054 | Jun 5, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 9, 2026MLABSEC Form 4 filed by Director Capone Mark ChristopherForm 4Grant or award
- Aug 15, 2026MLABDirector Capone Mark Christopher converted options into 2,784 shares, increasing direct ownership by 81% to 6,213 unitsForm 4Exercise or conversion of a derivative
- Jul 10, 2026SERADirector Capone Mark Christopher was granted 44,379 sharesForm 4Grant or award
- Jul 1, 2026SERAMark Christopher Capone became an insiderForm 3New insider
- Mar 10, 2026+$99.3KMLABDirector Capone Mark Christopher bought $99,331 worth of shares (1,301 units at $76.35), increasing direct ownership by 61% to 3,429 unitsForm 4Open-market purchase
- Aug 15, 2025MLABDirector Capone Mark Christopher converted options into 1,404 shares, increasing direct ownership by 194% to 2,128 unitsForm 4Grant or awardExercise or conversion of a derivative
- Aug 15, 2024MLABDirector Capone Mark Christopher converted options into 724 sharesForm 4Grant or awardExercise or conversion of a derivative
- Feb 15, 2024MLABSEC Form 4 filed by Capone Mark ChristopherForm 4Grant or award
- Jan 8, 2024MLABNew insider Capone Mark Christopher claimed no ownership of stock in the companyForm 3New insider
- Jun 1, 2023DMTKSEC Form 4 filed by Capone Mark ChristopherForm 4Grant or award
- Jul 18, 2022DMTKSEC Form 4: Capone Mark Christopher was granted 46,340 sharesForm 4Grant or award
- Jul 18, 2022DMTKMark Christopher Capone became an insiderForm 3New insider
Compare Mark Christopher Capone with
- Mark Christopher Capone vs Sanket Shah1 shared
- Mark Christopher Capone vs Zhenya Lindgardt1 shared
- Mark Christopher Capone vs Benjamin Jackson1 shared
- Mark Christopher Capone vs Dyaarl Lee Anderson Jr.1 shared
- Mark Christopher Capone vs Inglis Tiffany Eul Davis1 shared
- Mark Christopher Capone vs Shiraz Shabanali Ladiwala1 shared
Other insiders at the same companies
- Sanket ShahMLAB
- Benjamin JacksonSERA
- Inglis Tiffany Eul DavisSERA
- Dyaarl Lee Anderson Jr.SERA
- Zhenya LindgardtSERA
- Shiraz Shabanali LadiwalaMLAB
- Jennifer Sadie AlltoftMLAB
- Shannon HallMLAB
- John James SullivanMLAB
- R Tony TripenyMLAB
- Austin AertsSERA
- Scott GleasonSERA
- Siddhartha KadiaMLAB
- Joshua PhillipsSERA
- Mansoor Raza MirzaSERA
- Sandra AJ LawrenceSERA
Questions about Mark Christopher Capone
- What is Mark Christopher Capone's role at Mesa Laboratories Inc /co/?
- Mark Christopher Capone reports to the SEC as director at Mesa Laboratories Inc /co/ (MLAB), according to the latest filing on September 11, 2026. Mark Christopher Capone has also filed as director at Sera Prognostics, Inc. (SERA) and director at DermTech, Inc. (DMTK).
- How many shares does Mark Christopher Capone own?
- After the latest filing that states it, Mark Christopher Capone directly owned 6,213 shares of Mesa Laboratories Inc /co/ (MLAB), 44,379 shares of Sera Prognostics, Inc. (SERA) and 82,054 shares of DermTech, Inc. (DMTK). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Christopher Capone bought or sold stock recently?
- The most recent open-market purchase was on March 10, 2026: bought 1,301 shares of Mesa Laboratories Inc /co/ (MLAB) for $99.3K at an average of $76.35.
- How do I get alerts when Mark Christopher Capone files?
- Follow Mark Christopher Capone on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Christopher Capone filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Mark Christopher Capone (SEC CIK 0001352413). Totals count each trade once, skipping amendments whose original is on file, from Jul 21, 2022 on. View on SEC EDGAR · Get this as JSON